We are live on ! Find out more
Fayez Sarofim & Co

Fayez Sarofim & Co Portfolio holdings

AUM $39.1B
1-Year Est. Return 15.14%
This Fund
S&P 500
This Quarter Est. Return
+9.2%
1 Year Est. Return
+15.14%
3 Year Est. Return
+57.14%
5 Year Est. Return
+86.44%
10 Year Est. Return
+281.86%
AUM
$20.8B
AUM Growth
+$1.36B
Cap. Flow
-$242M
Cap. Flow %
-1.17%
Top 10 Hldgs %
41.79%
Holding
274
New
20
Increased
77
Reduced
99
Closed
5

Top Buys

Rank Stock Value
1
PGR icon
Progressive
PGR
+$27.7M
2
BKNG icon
Booking.com
BKNG
+$16.4M
3
AMZN icon
Amazon
AMZN
+$14.6M
4
BR icon
Broadridge
BR
+$12.5M
5
BX icon
Blackstone
BX
+$11.1M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$22.3M
2
MSFT icon
Microsoft
MSFT
+$18.7M
3
CB icon
Chubb
CB
+$16M
4
BUD icon
AB InBev
BUD
+$16M
5
JPM icon
JPMorgan Chase
JPM
+$15.7M

Sector Composition

Rank Sector Weight
1 Consumer Staples 23.04%
2 Financials 19.79%
3 Technology 15.34%
4 Energy 11.59%
5 Healthcare 9.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RETA
101
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$6.16M 0.03%
30,129
SBR
102
Sabine Royalty Trust
SBR
$1.06B
$6.09M 0.03%
151,249
AMGN icon
103
Amgen
AMGN
$209B
$6.05M 0.03%
25,084
+1,023
+4% +$226K
WYNN icon
104
Wynn Resorts
WYNN
$10.5B
$5.69M 0.03%
41,000
OKE icon
105
Oneok
OKE
$56.1B
$5.68M 0.03%
75,117
+600
+0.8% +$42.9K
LLY icon
106
Eli Lilly
LLY
$1.03T
$5.25M 0.03%
39,972
+23,450
+142% +$2.72M
SPY icon
107
State Street SPDR S&P 500 ETF Trust
SPY
$784B
$4.88M 0.02%
15,165
+8,728
+136% +$2.69M
CDK
108
DELISTED
CDK Global, Inc.
CDK
$4.61M 0.02%
84,315
-1,023
-1% -$52.6K
FOX icon
109
Fox Class B
FOX
$22B
$4.59M 0.02%
125,994
-90,066
-42% -$3.02M
UN
110
DELISTED
Unilever NV New York Registry Shares
UN
$4.49M 0.02%
78,054
+40,000
+105% +$2.36M
LEG icon
111
Leggett & Platt
LEG
$1.37B
$4.07M 0.02%
80,000
PLD icon
112
Prologis
PLD
$136B
$3.95M 0.02%
44,300
+7,400
+20% +$656K
IMO icon
113
Imperial Oil
IMO
$62.3B
$3.86M 0.02%
145,925
+1,000
+0.7% +$25.3K
VZ icon
114
Verizon
VZ
$193B
$3.84M 0.02%
62,536
+6,363
+11% +$384K
SJM icon
115
J.M. Smucker
SJM
$13.1B
$3.83M 0.02%
36,727
OXY icon
116
Occidental Petroleum
OXY
$55.6B
$3.7M 0.02%
89,842
-65,371
-42% -$2.62M
CL icon
117
Colgate-Palmolive
CL
$73.3B
$3.63M 0.02%
52,792
-2,855
-5% -$195K
COST icon
118
Costco
COST
$423B
$3.58M 0.02%
12,184
+101
+0.8% +$30K
SYY icon
119
Sysco
SYY
$40.6B
$3.46M 0.02%
40,490
+15
+0% +$1.22K
SCI icon
120
Service Corp International
SCI
$11.8B
$3.43M 0.02%
74,500
CAT icon
121
Caterpillar
CAT
$373B
$3.41M 0.02%
23,091
-1,775
-7% -$248K
BABA icon
122
Alibaba
BABA
$279B
$3.38M 0.02%
15,959
-1,480
-8% -$278K
BTI icon
123
British American Tobacco
BTI
$133B
$3.29M 0.02%
77,490
GOOGL icon
124
Alphabet (Google) Class A
GOOGL
$4.08T
$3.25M 0.02%
48,560
+1,100
+2% +$71K
NEE icon
125
NextEra Energy
NEE
$183B
$3.19M 0.02%
52,676
+2,900
+6% +$169K

Similar funds

Fayez Sarofim & Co's Q4 2019 Portfolio in Review

As of Q4 2019, Fayez Sarofim & Co held 274 positions worth $20.8B, up 7% from $19.4B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Fayez Sarofim & Co's Q4 2019 filing shows 20 new, 77 increased, 99 reduced and 5 closed positions. Its largest new stake was Williams Companies: 62,000 shares worth $1.47M. The largest sale was Apple, an estimated $22.3M.

By sector, the portfolio is most concentrated in Consumer Staples at 23% of assets, down from 24% a quarter earlier, followed by Financials and Technology.

  • Fayez Sarofim & Co's largest Q4 2019 buy was Williams Companies: 62,000 shares worth $1.47M.
  • Fayez Sarofim & Co added most to Progressive in Q4 2019, an estimated $27.7M increase.
  • Fayez Sarofim & Co's biggest Q4 2019 reduction was Apple, cutting an estimated $22.3M.
  • Fayez Sarofim & Co fully exited Charles Schwab in Q4 2019, selling an estimated $1.58M.
  • Fayez Sarofim & Co's ten largest holdings make up 42% of its $20.8B portfolio in Q4 2019.
  • Fayez Sarofim & Co opened 20 new positions and closed 5 in Q4 2019.
  • Fayez Sarofim & Co's portfolio value rose 7% quarter-over-quarter to $20.8B.

Based on Fayez Sarofim & Co's 13F filing for Q4 2019, filed 14 Feb 2020.